Nature Review Cardiology: Roadmap for alleviating the manifestations of ageing in the cardiovascular system 

Nature Review Cardiology: Roadmap for alleviating the manifestations of ageing in the cardiovascular system 

Ageing of the cardiovascular system is associated with frailty and various life-threatening diseases. As global populations grow older, age-related conditions increasingly determine healthspan and lifespan. The circulatory system not only supplies nutrients and oxygen to all tissues of the human body and removes by-products but also builds the largest interorgan communication network, thereby serving as a gatekeeper for healthy ageing. Therefore, elucidating organ-specific and cell-specific ageing mechanisms that compromise circulatory system functions could have the potential to prevent or ameliorate age-related cardiovascular diseases. In support of this concept, emerging evidence suggests that targeting the circulatory system might restore organ function.

A large consortium of aging scientists from around the world recently published a Roadmap article in Nature Review Cardiology delving into the organ-specific and cell-specific mechanisms that underlie ageing-related changes in the cardiovascular system. This effort raises unanswered questions regarding the optimal design of clinical trials, in which markers of biological ageing in humans could be assessed. It is intended to provide guidance for the development of gerotherapeutics, which will rely on the technological progress of the diagnostic toolbox to measure residual risk in elderly individuals. A major challenge in the quest to discover interventions that delay age-related conditions in humans is to identify molecular switches that can delay the onset of ageing changes. To overcome this roadblock, future clinical trials need to provide evidence that gerotherapeutics directly affect one or several hallmarks of ageing in such a manner as to delay, prevent, alleviate or treat age-associated dysfunction and diseases. 

Several EU-METAHEART members took part of this effort including Luca Liberale, Kostantinos Stellos, Gemma Vilahur, Simon Sedej, Judith Haendeler, Marinos Kallikourdis, Pasquale Maffia, Lina Badimon, Kimon S. Stamatelopoulos, and Mahmoud Abdellatif . 

Read more here https://www.nature.com/articles/s41569-025-01130-5

Share this post

Twitter
Facebook
LinkedIn
WhatsApp

Latest Updates

Euromit meeting

New Focus Issue Published: Metabolic alterations in heart failure

EU-METAHEART 2nd International Conference

Newsletter

Subscribe our Newsletter and stay up-to-date

Stay Up-to-date

Euromit meeting that will be held in the beautiful city of Angers, France, at the Convention Center, from May 30 to June 4, 2026. Euromit is the largest international conference on mitochondrial diseases in Europe....
In this Focus issue written by members of the EU-METAHEART collaboration, the authors explore the various ways in which metabolism is alterated in heart failure with either reduced or preserved ejection fraction....
The 2nd International Conference of our COST Action will take place from September 16th to 18th: please join online Zoom-Link for the scientific program: https://ukw-de.zoom.us/j/94587180921?pwd=7FL1wbN76QvjX2G3T45atBkuueyZK0.1 Meeting-ID: 945 8718 0921Code: 460208...
The PhD Program “Molecular Medicine” (Medical University of Graz), offers 14 PhD positions with a special focus on cancer research, aging, metabolic disorders, microbiome research as well as further topics....
New research led by the Heather group at the University of Oxford, UK, in collaboration with several EU-METAHEART members, has identified a new metabolic axis underpinning cardiac dysfunction in diabetes....
The University of Angers (France) is opening a Tenure-Track Junior Professor Chair in the field of rare mitochondrial diseases and therapeutic innovation. 🔬 Join the MitoVasc research unit (UA – CNRS – Inserm), a key...